The Antihelminthics Market is expected to register a CAGR of 4% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Antihelminthics Market Report is segmented by type into Benzimidazoles, Abamectin, Salicylanilides, and Praziquantel. The application segment includes Schistosomiasis, Fasciolasis, Filariasis, Angiostrongylosis, Ascariasis, and Giardiasis. The end-user segment includes Hospitals. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
The report Antihelminthics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
The regional trends and factors influencing the Antihelminthics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Antihelminthics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ XX million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2025 - 2031) | 4% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Antihelminthics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Antihelminthics Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The research report on the Antihelminthics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
The leading players of the market are: Sanofi, ZEISS International, Johnson and Johnson Services, Merck and Co., Inc., Abbott, Bayer AG, Astellas Pharma Inc., ALLERGAN, Novartis AG., GlaxoSmithKline Plc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Preventive measures including mass drug administration programs increase the scope for this market. Advances in diagnostic technologies will provide early detection and prompt treatment of helminth infections. The increasing prevalence of drug resistance among helminths is a significant challenge, and pharmaceutical companies are working on new antihelminthic agents to overcome this issue. Growing population and accelerating urbanization across the globe are expected to increase the demand for effective antihelminthic therapies, thereby driving growth in the market in the future.
Antihelminthics Market is expected to grow at a CAGR of 4% between 2023-2031
Several factors are driving the antihelminthics market. A major driver is the rising prevalence of helminth infections, especially in regions with poor sanitation and hygiene. Rising healthcare expenditure and investments in healthcare infrastructure, particularly in developing countries, are also propelling the market. In addition, growing awareness about preventive measures and early diagnosis of helminth infections is boosting demand. Increasing treatment reach to a larger population because of the availability of inexpensive and generic antihelminthic drugs further boosts the market.